Surgery Partners, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Surgery Partners, Inc. announced its second quarter 2026 financial results, reporting a net loss attributable to the company of $15.0 million, a wider loss compared to the prior year's $2.5 million, alongside a 2.7% increase in total revenues.
NASDAQ
Surgery Partners reported a 4.5% increase in Q1 2026 revenue to $810.9 million, driven by same-facility growth, though net loss attributable to the company widened to $35.9 million.
NASDAQ
Surgery Partners, Inc. reported a 6.6% increase in third-quarter revenues to $821.5 million, alongside an improved net loss of $22.7 million, though interest expenses rose significantly.
NASDAQ
Surgery Partners, Inc. reported an 8.3% revenue increase and reduced Q2 net loss, but saw a higher net loss and decreased operating cash flow for the first six months of 2025.
NASDAQ
Surgery Partners' Q1 2025 revenue increased by 8.2%, but the net loss attributable to the company widened to $37.7 million.
NASDAQ
Surgery Partners saw a revenue increase of 14.3% in the third quarter of 2024, but also experienced a net loss attributable to Surgery Partners, Inc. of $31.7 million.
NASDAQ
Surgery Partners' second quarter saw revenue growth driven by same-facility performance and acquisitions, but a net loss was reported due to increased expenses and debt extinguishment costs.
NASDAQ
Surgery Partners saw a 7.7% increase in revenue in the first quarter of 2024, driven by same-facility growth and strategic acquisitions.